Does TOFACITINIB Cause Lupus-like syndrome? 473 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 473 reports of Lupus-like syndrome have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.3% of all adverse event reports for TOFACITINIB.
473
Reports of Lupus-like syndrome with TOFACITINIB
0.3%
of all TOFACITINIB reports
312
Deaths
262
Hospitalizations
How Dangerous Is Lupus-like syndrome From TOFACITINIB?
Of the 473 reports, 312 (66.0%) resulted in death, 262 (55.4%) required hospitalization, and 244 (51.6%) were considered life-threatening.
Is Lupus-like syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 473 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Lupus-like syndrome?
INFLIXIMAB (2,158)
ADALIMUMAB (1,745)
METHOTREXATE (775)
ETANERCEPT (720)
ABATACEPT (644)
PREDNISONE (638)
TOCILIZUMAB (629)
CERTOLIZUMAB PEGOL (593)
HYDROXYCHLOROQUINE (593)
USTEKINUMAB (587)
Which TOFACITINIB Alternatives Have Lower Lupus-like syndrome Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN